Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.
Saved in:
| Title: | Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. |
|---|---|
| Authors: | Gozdecka M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Meduri E; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Mazan M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Tzelepis K; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Dudek M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Knights AJ; Genomics of Gene Regulation, Wellcome Trust Sanger Institute, Hinxton, UK., Pardo M; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Yu L; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Choudhary JS; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Metzakopian E; Mouse Genomics, Wellcome Trust Sanger Institute, Hinxton, UK., Iyer V; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Yun H; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Park N; Sequencing Research Group, Wellcome Trust Sanger Institute, Cambridge, UK., Varela I; Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain., Bautista R; New Pipeline Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Collord G; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Dovey O; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Garyfallos DA; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., De Braekeleer E; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Kondo S; Laboratory of Molecular Genetics, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Cooper J; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Göttgens B; Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK., Bullinger L; Department of Internal Medicine III, Ulm University Medical Centre, Ulm, Germany.; Medical Department, Division of Hematology, Oncology and Tumour Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany., Northcott PA; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA., Adams D; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Vassiliou GS; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. gsv20@sanger.ac.uk.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. gsv20@sanger.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@sanger.ac.uk., Huntly BJP; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. bjph2@cam.ac.uk. |
| Source: | Nature genetics [Nat Genet] 2022 Jul; Vol. 54 (7), pp. 1062. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35701672 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gozdecka+M%22">Gozdecka M</searchLink>; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Meduri+E%22">Meduri E</searchLink>; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Mazan+M%22">Mazan M</searchLink>; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Tzelepis+K%22">Tzelepis K</searchLink>; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Dudek+M%22">Dudek M</searchLink>; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Knights+AJ%22">Knights AJ</searchLink>; Genomics of Gene Regulation, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Pardo+M%22">Pardo M</searchLink>; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Yu+L%22">Yu L</searchLink>; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Choudhary+JS%22">Choudhary JS</searchLink>; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Metzakopian+E%22">Metzakopian E</searchLink>; Mouse Genomics, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Iyer+V%22">Iyer V</searchLink>; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Yun+H%22">Yun H</searchLink>; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Park+N%22">Park N</searchLink>; Sequencing Research Group, Wellcome Trust Sanger Institute, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Varela+I%22">Varela I</searchLink>; Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.<br /><searchLink fieldCode="AU" term="%22Bautista+R%22">Bautista R</searchLink>; New Pipeline Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Collord+G%22">Collord G</searchLink>; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Dovey+O%22">Dovey O</searchLink>; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Garyfallos+DA%22">Garyfallos DA</searchLink>; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22De+Braekeleer+E%22">De Braekeleer E</searchLink>; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Kondo+S%22">Kondo S</searchLink>; Laboratory of Molecular Genetics, Institute of Medical Science, University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Cooper+J%22">Cooper J</searchLink>; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Göttgens+B%22">Göttgens B</searchLink>; Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Bullinger+L%22">Bullinger L</searchLink>; Department of Internal Medicine III, Ulm University Medical Centre, Ulm, Germany.; Medical Department, Division of Hematology, Oncology and Tumour Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Northcott+PA%22">Northcott PA</searchLink>; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Adams+D%22">Adams D</searchLink>; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Vassiliou+GS%22">Vassiliou GS</searchLink>; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. gsv20@sanger.ac.uk.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. gsv20@sanger.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@sanger.ac.uk.<br /><searchLink fieldCode="AU" term="%22Huntly+BJP%22">Huntly BJP</searchLink>; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. bjph2@cam.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229216904%22">Nature genetics</searchLink> [Nat Genet] 2022 Jul; Vol. 54 (7), pp. 1062. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Co%22">Nature Pub. Co </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9216904 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-1718 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210614036%22">10614036 </searchLink><i>NLM ISO Abbreviation: </i>Nat Genet <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35701672 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41588-022-01060-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1062 Titles: – TitleFull: Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gozdecka M – PersonEntity: Name: NameFull: Meduri E – PersonEntity: Name: NameFull: Mazan M – PersonEntity: Name: NameFull: Tzelepis K – PersonEntity: Name: NameFull: Dudek M – PersonEntity: Name: NameFull: Knights AJ – PersonEntity: Name: NameFull: Pardo M – PersonEntity: Name: NameFull: Yu L – PersonEntity: Name: NameFull: Choudhary JS – PersonEntity: Name: NameFull: Metzakopian E – PersonEntity: Name: NameFull: Iyer V – PersonEntity: Name: NameFull: Yun H – PersonEntity: Name: NameFull: Park N – PersonEntity: Name: NameFull: Varela I – PersonEntity: Name: NameFull: Bautista R – PersonEntity: Name: NameFull: Collord G – PersonEntity: Name: NameFull: Dovey O – PersonEntity: Name: NameFull: Garyfallos DA – PersonEntity: Name: NameFull: De Braekeleer E – PersonEntity: Name: NameFull: Kondo S – PersonEntity: Name: NameFull: Cooper J – PersonEntity: Name: NameFull: Göttgens B – PersonEntity: Name: NameFull: Bullinger L – PersonEntity: Name: NameFull: Northcott PA – PersonEntity: Name: NameFull: Adams D – PersonEntity: Name: NameFull: Vassiliou GS – PersonEntity: Name: NameFull: Huntly BJP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2022 Jul Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1546-1718 Numbering: – Type: volume Value: 54 – Type: issue Value: 7 Titles: – TitleFull: Nature genetics Type: main |
| ResultId | 1 |
